(Finance) – Bausch + Lomba North American company active in the field of eye health, is landed today with the symbol “BLCO” on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange. Following the IPO, the parent company Bausch Healthtogether with its subsidiaries, will hold approximately 90% of the ordinary shares of Bausch + Lomb, or 88.5% of the ordinary shares if the over-allotment option is fully exercised.
“Today marks a huge milestone for Bausch + Lomb and a major step forward on the path to an independent company focused on eye health – said CEO Joseph Papa – Bausch + Lomb has long been associated with many of the most significant advances in eye health and I am honored to work alongside our 12,000 global employees as we continue to focus on achieving our ongoing mission of helping people see better to live better around the world. “
The actions of Bausch + Lomb opened at $ 18.50 per share, compared to the IPO price of $ 18 and an initial fork of $ 21-24. The stock then rose above $ 19.2, for a capitalization of over $ 6.5 billion. The IPO has raised $ 630 million for the selling shareholder, while Bausch + Lomb did not collect any amount from the transaction. This is the second largest listing on Wall Street since the beginning of the year, after that of the private equity giant TPG, which raised nearly $ 1 billion in January.